A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
A novel iPSC-derived lung-on-chip model mimics human alveolar tissue, revealing macrophage-driven tuberculosis responses.
NETs promote macrophage expression of T-cell chemokines and subsequently facilitate cytotoxic CD8+ T cell infiltration and granzyme B production, which drives kidney fibrosis in obstructive ...
BIRMINGHAM, Ala. – Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages — the white blood cells that defend the body by killing microbes, ...
When cancer cells begin to die within tumors, they expose signals on their surface that indicate they are dying. Macrophages then detect these signals and engage in phagocytosis, where they eat the ...
The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines. A drug injected directly ...
KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback